Modular synthesis of new C-aryl-nucleosides and their anti-CML activity

Bioorg Med Chem Lett. 2018 Jun 1;28(10):1931-1936. doi: 10.1016/j.bmcl.2018.03.063. Epub 2018 Mar 24.

Abstract

The C-aryl-ribosyles are of utmost interest for the development of antiviral and anticancer agents. Even if several synthetic pathways have been disclosed for the preparation of these nucleosides, a direct, few steps and modular approaches are still lacking. In line with our previous efforts, we report herein a one step - eco-friendly β-ribosylation of aryles and heteroaryles through a direct Friedel-Craft ribosylation mediated by bismuth triflate, Bi(OTf)3. The resulting carbohydrates have been functionalized by cross-coupling reactions, leading to a series of new C-aryl-nucleosides (32 compounds). Among them, we observed that 5d exerts promising anti-proliferative effects against two human Chronic Myeloid Leukemia (CML) cell lines, both sensitive (K562-S) or resistant (K562-R) to imatinib, the "gold standard of care" used in this pathology. Moreover, we demonstrated that 5d kills CML cells by a non-conventional mechanism of cell death.

Keywords: Anti-CML agents; Green chemistry; Modular syntheses; Nucleoside analogues.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Catalysis
  • Cell Proliferation / drug effects
  • Drug Resistance, Neoplasm / drug effects
  • Humans
  • Imatinib Mesylate / pharmacology
  • K562 Cells
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Mesylates / chemistry
  • Microtubule-Associated Proteins / metabolism
  • Nucleosides / chemical synthesis
  • Nucleosides / chemistry*
  • Nucleosides / pharmacology

Substances

  • Antineoplastic Agents
  • Mesylates
  • Microtubule-Associated Proteins
  • Nucleosides
  • Bi(OTf)3
  • Imatinib Mesylate